Efavirenz Completed Phase 3 Trials for Plasmodium Infections / Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00993031Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
NCT00978068HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children